Clinical Trial Disclosures: More Transparency In The Future?
Source: MMS Holdings
Ed Miseta, Editor of Clinical Leader, interviews Joe Archer, Associate Director of Trial Disclosure Services at MMS Holdings Inc. at DIA 2013. Archer discusses clinical trial disclosures, why they are important to the industry, the compliance level of companies, compliance by the international community, and whether we can expect more transparency in the future.
This website uses cookies to ensure you get the best experience on our website. Learn more